Authors : Dr. Shailendra Srivastava; Dr. Varun Khanna

Volume/Issue : Volume 9 - 2024, Issue 8 - August

Google Scholar : https://tinyurl.com/3h9xvvmp

Scribd : https://tinyurl.com/yenttzd3

DOI : https://doi.org/10.38124/ijisrt/IJISRT24AUG1497

Abstract : Our study explores the demographic profile, pain characteristics and treatment outcomes of a cohort 80 patients with clinically diagnosed osteoporosis (Mean age: 69.2 years). Eighty-eight point eight percent of individuals were female and the majority used anti- osteoporotic treatment (86.2%). Pain therapy: bisphosphonates, denosumab and teriparatide; 28.7% of patients with vertebral fractures were analyzed. Further it was revealed that significant differences between pain detection and symptom evaluation with deep discrepancies in the assessment of thoracic vs. lumbar pain according to statistical analysis (pain detection p < 0.0001, symptoms assessing p = 0.005) was present. Trends in the evolution of Numerical Rating Scale (NRS) scores for resting and moving pain were assessed. The results showed a slow decrease in pain intensity in both the resting and movement states. There was a statistically significant difference between rest and movement pain scores at the time of paired t-test (mean diff = 3.0375, t-value =14.1972, p value <0·0001).

Keywords : Osteoporosis, Pain Management, Vertebral Fractures, Numerical Rating Scale (NRS), Thoracic vs. Lumbar Pain.

References :

1. Al-Sari, U.A.; Tobias, J.; Clark, E. Health-related quality of life in older people with osteoporotic vertebral fractures: A systematic review and meta-analysis. Osteoporos. Int. 2016, 27, 2891–2900.
2. Fujiwara, S.; Zhao, X.; Teoh, C.; Jaffe, D.H.; Taguchi, Y. Disease burden of fractures among patients with osteoporosis in Japan: Health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J. Bone Miner. Metab. 2019, 37, 307–318.
3. Hallberg, I.; Rosenqvist, A.M.; Kartous, L.; Lofman, O.; Wahlstrom, O.; Toss, G. Health-related quality of life after osteoporotic fractures. Osteoporos. Int. 2004, 15, 834–841.
4. Lyles, K.W.; Gold, D.T.; Shipp, K.M.; Pieper, C.F.; Martinez, S.; Mulhausen, P.L. Association of osteoporotic vertebral compression fractures with impaired functional status. Am. J. Med. 1993, 94, 595–601.
5. Miyakoshi, N.; Itoi, E.; Kobayashi, M.; Kodama, H. Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis. Osteoporos. Int. 2003, 14, 1007–1012.
6. Nakamura, K. A “super-aged” society and the “locomotive syndrome”. J. Orthop. Sci. 2008, 13, 1–2.
7. Kanis, J.A.; Jonsson, B. Economic evaluation of interventions for osteoporosis. Osteoporos. Int. 2002, 13, 765–767.
8. Hamasaki, T.; Okimoto, N.; Teramoto, H.; Shirakawa, T.; Nakagawa, T.; Mizuno, N.; Yamasaki, T.; Sasashige, Y.; Fujiwara, S. Incidence of clinical vertebral fractures and hip fractures of the elderly (65 years or over) population-large-scale data analysis using claim database in Kure City, Hiroshima, Japan. Arch. Osteoporos. 2020, 15, 124.
9. Hofler, R.C.; Jones, G.A. Bracing for Acute and Subacute Osteoporotic Compression Fractures: A Systematic Review of the Literature. World Neurosurg. 2020, 141, e453–e460.
10. Longo, U.G.; Loppini, M.; Denaro, L.; Maffulli, N.; Denaro, V. Conservative management of patients with an osteoporotic vertebral fracture: A review of the literature. J. Bone Jt. Surg. 2012, 94, 152–157.
11. Closs, S.J.; Barr, B.; Briggs, M.; Cash, K.; Seers, K. A comparison of five pain assessment scales for nursing home residents with varying degrees of cognitive impairment. J. Pain Symptom Manag. 2004, 27, 196–205.
12. Dang, H.; Stafseth, S.K. Documentation for Assessing Pain in Postoperative Pain Management Pre- and Post-intervention. J. Perianesthesia Nurs. 2023, 38, 88–95.
13. Fry, M.; Arendts, G.; Chenoweth, L. Emergency nurses’ evaluation of observational pain assessment tools for older people with cognitive impairment. J. Clin. Nurs. 2017, 26, 1281–1290.
14. Kim, Y.S.; Park, J.M.; Moon, Y.S.; Han, S.H. Assessment of pain in the elderly: A literature review. Natl. Med. J. India 2017, 30, 203–207. [Google Scholar] [PubMed]
15. Warnky, D.M.; Diebolt, J.H.; Ho, B.V.; Brake, A.D.; French, E.L.; Villwock, M.R.; Sykes, K.J.; Villwock, J.A. Investigation of a Novel Activity-Based Checks (ABC) Functional Pain Scale in the Post-Operative Urologic Surgery Patient. Kans. J. Med. 2023, 16, 35–40.
16. Herr, K.; Coyne, P.J.; Ely, E.; Gelinas, C.; Manworren, R.C.B. Pain Assessment in the Patient Unable to Self-Report: Clinical Practice Recommendations in Support of the ASPMN 2019 Position Statement. Pain Manag. Nurs. 2019, 20, 404–417.
17. Wynne, C.F.; Ling, S.M.; Remsburg, R. Comparison of pain assessment instruments in cognitively intact and cognitively impaired nursing home residents. Geriatr. Nurs. 2000, 21, 20–23.
18. Barzanji, A.; Zareiyan, A.; Nezamzadeh, M.; Mazhari, M.S. Evaluation of Observational and Behavioural Pain Assessment Tools in Nonverbal Intubated Critically Adult Patients after Open—Heart Surgery: A Systematic Review. Open Access Maced. J. Med. Sci. 2019, 7, 446–457.
19. Hagstrom, S.; O’Conner-Von, S.; Tracy, M.F. Survey of Nurses’ Use of the Clinically Aligned Pain Assessment (CAPA) Tool. Pain Manag. Nurs. 2022, 23, 568–575.
20. Hughes, J.D.; Chivers, P.; Hoti, K. The Clinical Suitability of an Artificial Intelligence-Enabled Pain Assessment Tool for Use in Infants: Feasibility and Usability Evaluation Study. J. Med. Internet Res. 2023, 25, e41992
21. Lichtner, V.; Dowding, D.; Esterhuizen, P.; Closs, S.J.; Long, A.F.; Corbett, A.; Briggs, M. Pain assessment for people with dementia: A systematic review of systematic reviews of pain assessment tools. BMC Geriatr. 2014, 14, 138.
22. Lukas, A.; Niederecker, T.; Gunther, I.; Mayer, B.; Nikolaus, T. Self- and proxy report for the assessment of pain in patients with and without cognitive impairment: Experiences gained in a geriatric hospital. Z. Gerontol. Geriatr. 2013, 46, 214–221.
23. Ngu, S.S.; Tan, M.P.; Subramanian, P.; Abdul Rahman, R.; Kamaruzzaman, S.; Chin, A.V.; Tan, K.M.; Poi, P.J. Pain Assessment Using Self-reported, Nurse-reported, and Observational Pain Assessment Tools among Older Individuals with Cognitive Impairment. Pain Manag. Nurs. 2015, 16, 595–601.
24. Hartrick, C.T.; Kovan, J.P.; Shapiro, S. The numeric rating scale for clinical pain measurement: A ratio measure? Pain Pract. Off. J. World Inst. Pain 2003, 3, 310–316.
25. Takai, Y.; Yamamoto-Mitani, N.; Chiba, Y.; Nishikawa, Y.; Hayashi, K.; Sugai, Y. Abbey Pain Scale: Development and validation of the Japanese version. Geriatr. Gerontol. Int. 2010, 10, 145–153.
26. Wary, B.; Doloplus, C. Doloplus-2, a scale for pain measurement. Soins Gerontol. 1999, 19, 25–27.
27. Qaseem A, Snow V, Shekelle P, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;149:404–15.
28. Russell RG. Bisphosphonates: The first 40 years. Bone. 2011;49:2–19.
29. Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: A potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294–301.
30. Yates J. A meta-analysis characterizing the dose-response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women. Osteoporos Int. 2013;24:253–62.
31. Zhang J, Wang R, Zhao YL, et al. Efficacy of intravenous zoledronic acid in the prevention and treatment of osteoporosis: A meta-analysis. Asian Pac J Trop Med. 2012;5:743–8.
32. Crandall CJ, Newberry SJ, Diamant A, et al. Comparative effectiveness of pharmacologic treatments to prevent fractures: An updated systematic review. Ann Intern Med. 2014;161:711–23.
33. Barrionuevo P, Kapoor E, Asi N, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: A network meta-analysis. J Clin Endocrinol Metab. 2019;104:1623–30.
34. Freemantle N, Cooper C, Diez-Perez A, et al. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: A meta-analysis. Osteoporos Int. 2013;24:209–17.
35. Hak DJ, Fitzpatrick D, Bishop JA, et al. Delayed union and nonunions: Epidemiology, clinical issues, and financial aspects. Injury. 2014;45–7.
36. Hegde V, Jo JE, Andreopoulou P, et al. Effect of osteoporosis medications on fracture healing. Osteoporos Int. 2016;27:861–71.
37. Saito T, Sterbenz JM, Malay S, et al. Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: Systematic review and meta-analysis. Osteoporos Int. 2017;28:3289–300.
38. Duckworth AD, McQueen MM, Tuck CE, et al. Effect of alendronic acid on fracture healing: A multicenter randomized placebo-controlled trial. J Bone Miner Res. 2019;34:1025–32.
39. Lim EJ, Kim JT, Kim CH, et al. Effect of preoperative bisphosphonate treatment on fracture healing after internal fixation treatment of intertrochanteric femoral fractures. Hip Pelvis. 2019;31:75–81.
40. Goodship AE, Walker PC, McNally D, et al. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994;5–5.
41. Peter CP, Cook WO, Nunamaker DM, et al. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res. 1996;14:74–9.
42. Miettinen SS, Jaatinen J, Pelttari A, et al. Effect of locally administered zoledronic acid on injury-induced intramembranous bone regeneration and osseointegration of a titanium implant in rats. J Orthop Sci. 2009;14:431–6.
43. Skripitz R, Johansson HR, Ulrich SD, et al. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci. 2009;14:138–43.
44. Hanley DA, Adachi JD, Bell A, et al. Denosumab: Mechanism of action and clinical outcomes. Int J Clin Pract. 2012; 66:1139–46.
45. Bone HG, Bolognese MA, Yuen CK, et al. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab. 2011;96:972–80.
46. Papaionnou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary. CMAJ. 2010; 182:1864–73.
47. Papapoulos S, Chapurlat R, Libanati C, et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension. J Bone Miner Res. 2012;27:694–701.
48. Seeman E, Delmas PD, Henley DA, et al. Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate. J Bone Miner Res. 2010;25:1886–94.
49. Lv Fang, Cai X, Yang W, et al. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta-analysis. Bone. 2020;130:115121.